Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

GNMX vs PBPH: Holdings Overlap & Returns

Share
Share on XDownload as PDF

GNMX and PBPH hold 7% of their weight in the same names.

askIQ about this page

askIQ about GNMX and PBPH

Net assets: $1.3m on Nov 4, 2026 for Corgi Genomics & Precision Medicine ETF, and $952m on Jul 31, 2026 for Portfolio Building Block World Pharma and Biotech Index ETF.

At a glance
31.0%
GNMX in the S&P 500
59.2%
PBPH in the S&P 500
+48.3%
GNMX total return, 6 months
+27.0%
PBPH total return, since launch, Nov 25, 2025
GNMX · 6 months to Nov 4, 2026 69% of its weight is outside the S&P 500
69% of its weight is outside the S&P 50031% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.31%69%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 49% of the fund · 57 holdings as published by its issuer for Nov 4, 2026 · Nasdaq-100: 8% in69% of its weight is outside the S&P 50031% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.31%69%inoutside the S&P 500active share 99% · Nasdaq-100: 8% in

31% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.

PBPH · 6 months to Nov 4, 2026 41% of its weight is outside the S&P 500
41% of its weight is outside the S&P 50059% of PBPH's weight is in S&P 500 companies and 41% is outside the index. Holdings as of Jul 31, 2026.59%41%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 95% · top ten 62% of the fund · 53 holdings as filed for Jul 31, 2026 · Nasdaq-100: 14% in41% of its weight is outside the S&P 50059% of PBPH's weight is in S&P 500 companies and 41% is outside the index. Holdings as of Jul 31, 2026.59%41%in the S&P 500outsideactive share 95% · Nasdaq-100: 14% in

59% of PBPH's weight is in S&P 500 companies and 41% is outside the index. Holdings as of Jul 31, 2026.

Pair scorecard

PBPH costs 0.22 points a year less.

GNMX vs PBPH: Holdings Overlap & Returns
MeasureGNMXPBPH
Benchmark
What it tracksGenomics and gene editingBiotech
Cost and size
Expense ratio0.35%0.13%
Net assets, GNMX as of Nov 4, 2026 and PBPH as of Jul 31, 2026$1.3m$952m
Holdings
Holdings in common7%

Method

What they share

7%

By the books each fund has filed, GNMX and PBPH hold 7% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Nov 4, 2026.

0 half 100%

half

7% in common

Positions both hold · largest shared weight first GNMX PBPH
Vertex Pharmaceuticals Inc 6.04% 2.82%
Revolution Medicines Inc 3.24% 0.77%
Illumina Inc 3.92% 0.72%
Alnylam Pharmaceuticals Inc 1.69% 0.63%
Incyte Corp 2.70% 0.56%
Moderna Inc 11.24% 0.45%
Genmab A/S 4.39% 0.40%
BioMarin Pharmaceutical Inc 1.89% 0.27%
Ionis Pharmaceuticals Inc 1.01% 0.18%
Only in one fund ↓
Only in GNMX
Thermo Fisher Scientific Inc 8.88%
Guardant Health Inc 3.45%
10X Genomics Inc 2.87%
CareDx Inc 2.43%
Twist Bioscience Corp 2.32%
GRAIL Inc 2.26%
Bio-Techne Corp 2.10%
QIAGEN NV 2.08%
Only in PBPH
ELI LILLY & COMPANY 15.20%
JOHNSON & JOHNSON 9.66%
ABBVIE INC 6.94%
MERCK & COMPANY INC 5.04%
ROCHE HOLDING AG 4.74%
AMGEN INC 4.63%
NOVARTIS AG 4.47%
ASTRAZENECA PLC 3.90%
Check overlap with more funds →

Window by window

Window by window: GNMX vs PBPH: Holdings Overlap & Returns
Total return
WindowGNMXPBPH
3 months+24.3%+16.2%
6 months+48.3%+25.6%
Since launchNot the same days: GNMX May 2026 · PBPH Nov 2025+48.3%+27.0%

Open this comparison in the app →

Side by side

GNMX Corgi Genomics & Precision Medicine ETF · Holds 57 stocks in genomics and gene editing, 31% of its weight in S&P 500 companies PBPH Portfolio Building Block World Pharma and Biotech Index ETF · Holds 53 stocks in biotech, 59% of its weight in S&P 500 companies
Theme Genomics and gene editing Biotech
In the S&P 500 31.0% 59.2%
Active share vs the S&P 500 99.4% 95.0%
In the Nasdaq-100 7.7% 13.6%
Holdings 57 53
Top ten, share of the fund 49.2% 61.9%
Expense ratio 0.35% 0.13%
Fee for the differing part 0.35% 0.14%
Total return, 1 year +48.3% (since launch, May 6, 2026) +27.0% (since launch, Nov 25, 2025)
vs its benchmark not measured not measured
Below its high −4.2% 0.0%
Net assets, GNMX as of Nov 4, 2026 and PBPH as of Jul 31, 2026 $1.3m $952m

As of Nov 4, 2026. Source: ETFIQ.

7% of the two portfolios are the same securities at the same weight.

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
GNMX

By weight, 31% of GNMX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 49% of the fund across 57 positions, as published by its issuer for Nov 4, 2026. Since it first traded on May 6, 2026 the fund returned +48.3% with distributions reinvested.

PBPH

By weight, 59% of PBPH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 95%. The top ten holdings are 62% of the fund across 53 positions, as filed for Jul 31, 2026. Since it first traded on Nov 25, 2025 the fund returned +27.0% with distributions reinvested.

Questions people ask

Do GNMX and PBPH hold the same stocks?
By their latest filings, 7% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, GNMX or PBPH?
GNMX has 31% of its weight in S&P 500 names and PBPH has 59%, so GNMX differs more from the index.
Which is cheaper, GNMX or PBPH?
GNMX charges 0.35% a year and PBPH charges 0.13%, so PBPH is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, GNMX against PBPH, data as of Nov 4, 2026. https://etfiq.com/compare/themes/gnmx-vs-pbph

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.